This website has been developed and funded by Piramal Critical Care UK and is intended for Healthcare professionals.
Click here to view prescribing information.
Adverse event reporting information can be found at the bottom of this page.
The NEW Ropivacaine ReadyfusOR (TM) from Piramal Critical Care UK is a self-contained infusion system pre-filled at the manufacturing site with 250 ml ropivacaine 0.2%. Once activated, Ropivacaine ReadyfusOR (TM) delivers a continuous infusion at a constant flow rate of 5 ml per hour over a period of 48 hours.
Ropivacaine ReadyfusOR (TM) is used for acute, postoperative pain management in adults.
Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard
Any suspected adverse reaction must be reported by email to pv.safety@piramal.com or telephone UK (toll free) 08007 563 979
We have created these handy CONTINUOUS WOUND INFUSION CATHETER INSERTION GUIDES. They are A5 and cover these topics;
1. Rectus sheath catheter: Landmark-guided approach
2. Abdominoplasty: With rectus plication
3. Lower segment caesarean section
4. Breast augmentation
5. Breast reconstruction
6. Sternotomy
7. Total knee arthroplasty
For more information please click here: